Physiological Reports · 2015 · 18 citations · 15 references
MedicineEndocrinologyGeneticsAndrologyHuman GeneticsSteroid BiochemistryAndrogen PhysiologyHormonal EvaluationMale Reproductive EndocrinologySteroidogenesis GeneticsTesticular FunctionTesticular PhysiologyAdrenal Steroid ProfilingCompetitive AthletesEndogenous Steroid MarkersGene DeletionSerum Testosterone MeasurementSex Steroid MeasurementSteroid Metabolite ProfilingUrinary Steroid Analysis
The measurement of the testosterone to epitestosterone ratio (T/E ratio) in urine is often used as a marker for testosterone administration in the doping control field. This study examines the frequencies of the different expression forms of the UGT2B17 gene, and assesses their effects on this marker in volunteer subjects. The sample for this descriptive study was composed of male and female athletes aged between 16 and 55 years old who practiced different sports disciplines. All participants underwent a sports-medical physical examination, and subsequently provided 10 urine samples consecutively over a period of 48 h. The dependent variable examined was T/E and the main independent variable was the UGT2B17 gene polymorphism. During 1 year, 1410 urine samples were obtained from 141 athletes. The frequencies of the three genotypes were as follows: wt homozygotes (ins/ins) 48.2% (n = 68), mutant homozygotes (del/del) 12.1% (n = 17), and heterozygotes (ins/del) 39.7% (n = 56). Genotype distributions varied significantly (P < 0.001) according to ethnicity, 80% of Asian subjects being homozygous for the gene deletion (del/del) compared to 6.9% of Caucasian subjects. A multivariate analysis adjusted for genotype, age, sex, and sports discipline revealed that athletes with the del/del polymorphism showed a significantly lower mean T/E than heterozygotes (ins/del). In contrast, homozygous athletes for the gene insertion (ins/ins) showed higher mean T/E ratios than heterozygotes (ins/del). UGT2B17 gene deletion has a strong influence on the T/E ratio in urine, which is the most efficient indicator of testosterone prohormone misuse. Others factors studied seem not to have such an impact. The genotyping of UGT2B17 is an important source of information for understanding steroid profiling in the doping control field; therefore it is suggested that it be included in the Athletes Biological Passport.
15
Jenny Jakobsson, Lena Ekström, Nobuo Inotsume et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 282 citations
Medicine, Endocrinology, Genetics +14
Jenny J. Schulze, Jonas Lundmark, Mats Garle et al. · The Journal of Clinical Endocrinology & Metabolism · 2008 · 186 citations · Full text
Medicine, Endocrinology, Genetics +17
Bayesian detection of abnormal values in longitudinal biomarkers with an application to T/E ratio
Pierre‐Edouard Sottas, N Baume, C Saudan et al. · Biostatistics · 2006 · 153 citations · Full text
Pharmacy, Biostatistics, Toxicology +17
The UGT2B17 gene deletion polymorphism and risk of prostate cancer
Carla J. Gallagher, Fred F. Kadlubar, Joshua Muscat et al. · Cancer Detection and Prevention · 2007 · 65 citations · Full text